-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VFIKC4LVZiM7+imoXYxkLLDrp6p98klVddBxBsNiBc/dT80IJmzA7/S1g0ZLPeek Jm6QplhTxw1IM92vjbBIWw== 0001209191-09-049088.txt : 20091019 0001209191-09-049088.hdr.sgml : 20091019 20091019171409 ACCESSION NUMBER: 0001209191-09-049088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091015 FILED AS OF DATE: 20091019 DATE AS OF CHANGE: 20091019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WYETH CENTRAL INDEX KEY: 0000005187 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 132526821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9736605000 MAIL ADDRESS: STREET 1: 5 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HOME PRODUCTS CORP DATE OF NAME CHANGE: 20020308 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN HOME PRODUCTS CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Germano Geno J CENTRAL INDEX KEY: 0001424383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01225 FILM NUMBER: 091126480 MAIL ADDRESS: STREET 1: 5 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2009-10-15 1 0000005187 WYETH WYE 0001424383 Germano Geno J 5 GIRALDA FARMS MADISON NJ 07940 0 1 0 0 Pres.-US Pharm. & Wom. Health. Common Stock 2009-10-15 4 D 0 23000 49.58 D 20556.8849 D Common Stock 2009-10-15 4 D 0 20556.8849 D 0 D Common Stock 2009-10-15 4 D 0 1530.974 D 0 I By reporting person as PUTMA custodian for children Phantom Stock Units 2009-10-15 4 D 0 1929.16 D Common Stock 1929.16 0 I SESP Employee Stock Option 56.5938 2009-10-15 4 D 0 18000 0.00 D Common Stock 18000 0 D Employee Stock Option 56.525 2009-10-15 4 D 0 20000 0.00 D Common Stock 20000 0 D Employee Stock Option 60.705 2009-10-15 4 D 0 22000 0.00 D Common Stock 22000 0 D Employee Stock Option 34.675 2009-10-15 4 D 0 1 14.905 D Common Stock 1 0 D Employee Stock Option 41.05 2009-10-15 4 D 0 20000 8.53 D Common Stock 20000 0 D Employee Stock Option 40.22 2009-10-15 4 D 0 36000 9.36 D Common Stock 36000 0 D Employee Stock Option 43.57 2009-10-15 4 D 0 30000 6.01 D Common Stock 30000 0 D Employee Stock Option 48.22 2009-10-15 4 D 0 30000 1.36 D Common Stock 30000 0 D Employee Stock Option 56.00 2009-10-15 4 D 0 40000 0.00 D Common Stock 40000 0 D Employee Stock Option 44.56 2009-10-15 4 D 0 50000 5.02 D Common Stock 50000 0 D Represents restricted stock units. Pursuant to the Agreement and Plan of Merger by and among Wyeth, Pfizer Inc. and Wagner Acquisition Corp., dated as of January 25, 2009 (as amended, the "Merger Agreement"), each restricted stock unit was cancelled at the effective time of the merger in exchange for cash equal to the per share value of the merger consideration of $49.58, less any applicable tax withholding. Represents Wyeth common stock. Pursuant to the Merger Agreement, each of these shares was cancelled at the effective time of the merger and converted into the right to receive $33.00 in cash and 0.985 of a share of Pfizer Inc. common stock, less any applicable tax withholding. Pursuant to the Merger Agreement, each phantom stock unit in the Supplemental Employee Savings Plan ("SESP") was converted at the effective time of the merger into the the right to receive an amount equal to notional $33.00 in cash plus 0.985 of a phantom share of Pfizer Inc. common stock in accordance with the SESP. Represents phantom stock units in the SESP. Pursuant to the Merger Agreement, each outstanding and unexercised option, whether vested or unvested, was cancelled at the effective time of the merger in exchange for cash equal to the product of (a) the number of shares underlying such option and (b) the excess, if any, of the per share value of the merger consideration of $49.58 over the per share exercise price of the option, less any applicable tax withholding. Tara J. Gabbai, Attorney-in-Fact for Geno J. Germano 2009-10-19 -----END PRIVACY-ENHANCED MESSAGE-----